Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia

The New England Journal of Medicine
C H PuiW E Evans

Abstract

Recombinant human granulocyte colony-stimulating factor PO1 CA-20180ilgrastim) hastens the recovery from neutropenia after P30 CA-21765emotherapy, but its role in the management of childhood leukemia is unclear. We randomly assigned 164 patients with acute lymphoblastic leukemia (age range, 2 months to 17 years) to receive placebo or G-CSF (10 microg per kilogram of body weight per day subcutaneously), beginning one day after the completion of remission-induction therapy and continuing until the neutrophil count was greater than or equal to 1000 per cubic millimeter for two days. The clinical and laboratory effects of this therapy were documented for 21 days. The area under the plasma G-CSF concentration-time curve was measured on days 1 and 7 in both groups. Responses to the growth factor could be assessed in 148 patients (73 in the G-CSF group and 75 in the placebo group). G-CSF treatment did not significantly lower the rate of hospitalization for febrile neutropenia (58 percent in the G-CSF group vs. 68 percent in the placebo group; relative risk, 0.85; 95 percent confidence interval, 0.59 to 1.16), increase the likelihood of event-free survival at three years (83 percent in both groups), or decrease the number of severe inf...Continue Reading

References

Dec 29, 1977·The New England Journal of Medicine·W T HughesS L George
Jul 9, 1992·The New England Journal of Medicine·G J Lieschke, A W Burgess
Nov 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W T HughesL S Young
Jun 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W L FurmanV M Santana
Jun 25, 1987·The New England Journal of Medicine·W T HughesL Lott
Sep 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R A StahelE Platzer
Jun 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T R KlumppJ S Macdonald
Jun 7, 1995·Journal of the National Cancer Institute·J I MayordomoI García-Ribas
Jun 15, 1995·The New England Journal of Medicine·C H Pui
Mar 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·G Blomqvist
Nov 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

❮ Previous
Next ❯

Citations

Jul 28, 2005·Annals of Hematology·Michael Heuser, Arnold Ganser
Jul 23, 1998·Prostaglandins & Other Lipid Mediators·G L DeliliersM Marconi
Jan 28, 1999·Leukemia Research·O G Ottmann, D Hoelzer
Nov 25, 2000·International Journal of Antimicrobial Agents·P Martino, C Girmenia
Nov 27, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R HauptE Castagnola
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J M MichonT Philip
Feb 14, 2002·British Journal of Haematology·Thomas Lehrnbecher, Karl Welte
Jun 19, 1997·The New England Journal of Medicine·D Hoelzer
Feb 12, 1998·The New England Journal of Medicine·P Gupta
Aug 27, 1998·The New England Journal of Medicine·C H Pui, W E Evans
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D A StevensG A Pankey
Oct 20, 1998·Thyroid : Official Journal of the American Thyroid Association·P MezquitaF Escobar-Jimenez
Oct 23, 1997·Journal of the National Cancer Institute·W B Ershler, D L Longo
Feb 21, 2002·Journal of the National Cancer Institute·Scott D RamseyDavid R Gandara
Feb 25, 2000·Current Opinion in Oncology·C H Pui
Feb 17, 2000·Current Opinion in Pediatrics·S K Parsons
Jun 10, 2003·Journal of Pediatric Hematology/oncology·Olga Bessmertny, Mitchell S Cairo
May 5, 1999·Current Opinion in Hematology·G H Lyman, L Balducci
Nov 19, 2004·Current Opinion in Hematology·Parinda A Mehta, Stella M Davies
Nov 12, 2005·Journal of Pediatric Hematology/oncology·Esther M te PoeleEvelina S J M de Bont
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sheri L SpuntVictor M Santana
Apr 20, 2001·Paediatric Drugs·L M Wagner, W L Furman
Oct 31, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Elio CastagnolaRiccardo Haupt
Dec 24, 2015·Leukemia & Lymphoma·Masahito TsurusawaUNKNOWN lymphoma committee of the Japanese Pediatric Leukemia/lymphoma Study Group
Dec 2, 2004·Expert Opinion on Biological Therapy·Rami S Komrokji, Gary H Lyman
Sep 27, 2003·British Journal of Haematology·Antonio PagliucaUNKNOWN Haemato-Oncology Task Force of the British Committee for Standards in Haematology
Jun 21, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Elio CastagnolaRiccardo Haupt
May 18, 2001·Best Practice & Research. Clinical Haematology·P B LangmuirB J Lange
Apr 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John A HeathUNKNOWN Children's Cancer Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.